Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Alpaslan Kilicarslan"'
Autor:
Umit Yasar, Atilla Bozkurt, Alpaslan Kilicarslan, Yildiz Yardimci, Melih O. Babaoglu, Gulay Sain-Guven
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 109:73-77
HMG-CoA reductase inhibitors (statins) have a potential to interact with substrates of the drug-metabolizing enzyme cytochrome P450 2C9 (CYP2C9). This may lead to concentration-dependent toxicity such as skeletal muscle side effects. Atorvastatin, a
Autor:
Mine Durusu Tanriover, Gamze Bora Tatar, Didem Dayangaç Erden, Tenzile Deniz Uluturk, Gulay Sain Guven, Tumay Sozen, Alpaslan Kilicarslan, Hayat Erdem Yurter, S. Gul Oz, Altug Tanriover
Publikováno v:
Clinical Rheumatology. 29:1285-1293
The aim of this study is to evaluate the effects of estrogen receptor 1 (ESR1) and vitamin D receptor (VDR) gene polymorphisms on bone mineral density (BMD) in a group of previously untreated osteoporotic women. Effects of demographic, environmental,
Autor:
Osman Saracbasi, Alpaslan Kilicarslan, Ercan Turkmen, Mine Durusu Tanriover, Altug Tanriover, Mazhar Tokgozoglu, S. Gul Oz, Gulay Sain Guven, Tumay Sozen
Publikováno v:
Archives of Gerontology and Geriatrics. 50:e13-e18
Hip fractures are a burden to both society and the individual. The aim of this study was to describe the frequency of osteoporosis and the in-hospital treatment costs of patients with hip fractures admitted to Hacettepe University Faculty of Medicine
Autor:
Necla Ozer, Tumay Sozen, Alpaslan Kilicarslan, Gulay Sain Guven, Yavuz Beyazit, Enver Atalar, Murat Kekilli, Ibrahim C. Haznedaroglu, Gul Oz, Levent Şahiner, Bunyamin Yavuz
Publikováno v:
Blood Coagulation & Fibrinolysis. 19:310-314
Procoagulant state, inflammation, and endothelial dysfunction have been documented in metabolic syndrome. Endothelial dysfunction is a strong predictor of cardiovascular events. Studies on the association of thrombin-activatable fibrinolysis inhibito
Autor:
Özlem Fentoğlu, Alpaslan Kilicarslan, Yasar Aykac, S. Gul Oz, Tumay Sozen, Gulay Sain Guven, Mine Durusu Tanrtover
Publikováno v:
Southern Medical Journal. 100:686-691
Background The authors aimed to evaluate whether local periodontal therapy may influence plasma lipid levels in patients with periodontitis. Methods Fifty patients (31 females and 19 males, age 36-66 yr) were randomly assigned to the treatment and co
Autor:
Alpaslan Kilicarslan, Mehlika Isildak, S. Gul Oz, Erdem Karabulut, Gulay Sain Guven, Tumay Sozen, Aylin Hasbay
Publikováno v:
The Endocrinologist. 17:85-88
Autor:
Anja Beilfuss, Lars P. Bechmann, Jan-Peter Sowa, Alpaslan Kilicarslan, Frieder Berr, Andreas Geier, Guido Gerken, Christian Rust, Rebekka A. Hannivoort, Johannes Schmitt, Ali Canbay, Martin Schlattjan, Peri Kocabayoglu, Scott L. Friedman, Oliver Tschopp, Svenja Sydor, Jan Best
Publikováno v:
Hepatology (Baltimore Md.)
Hepatology, 57(4), 1394-1406. Wiley
Hepatology, 57(4), 1394-1406. Wiley
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in industrialized countries and may proceed to steatohepatitis (NASH). Apoptosis and free fatty acid (FFA)-induced lipotoxicity are important features of NASH pathogenesis. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64b97ffe77243584dff396d627a0e878
https://biblio.vub.ac.be/vubir/free-fatty-acids-repress-small-heterodimer-partner-shp-activation-and-adiponectin-counteracts-bile-acidinduced-liver-injury-in-superobese-patients-with-nonalcoholic-steatohepatitis(2dab6c9a-f939-48c7-abc9-a6355f899973).html
https://biblio.vub.ac.be/vubir/free-fatty-acids-repress-small-heterodimer-partner-shp-activation-and-adiponectin-counteracts-bile-acidinduced-liver-injury-in-superobese-patients-with-nonalcoholic-steatohepatitis(2dab6c9a-f939-48c7-abc9-a6355f899973).html
Autor:
Guido Gerken, Alexander Wree, Martin Pronadl, Svenja Sydor, Alisan Kahraman, Ali Canbay, Martin Schlattjan, Anja Beilfuss, Akif Altinbas, Jan-Peter Sowa, Alpaslan Kilicarslan, Lars P. Bechmann, Wing-Kin Syn
Fetuin-A is a pro-inflammatory protein expressed by hepatocytes. Its course in morbidly obese patients with NAFLD (non-alcoholic fatty liver disease) following weight loss by BAS (bariatric surgery) has not been fully elucidated yet. In the present s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f23f8fe169d25677ac50227591c83bc
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84880171111
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84880171111
Autor:
Umit, Yasar, Gulay, Sain-Guven, Yildiz, Yardimci, Alpaslan, Kilicarslan, Melih O, Babaoglu, Atilla, Bozkurt
Publikováno v:
Basicclinical pharmacologytoxicology. 109(2)
HMG-CoA reductase inhibitors (statins) have a potential to interact with substrates of the drug-metabolizing enzyme cytochrome P450 2C9 (CYP2C9). This may lead to concentration-dependent toxicity such as skeletal muscle side effects. Atorvastatin, a
Publikováno v:
The spine journal : official journal of the North American Spine Society. 9(4)
Background context Pregnancy- and lactation-associated osteoporosis is an uncommon condition that may be a consequence of preexisting low bone density, loss of bone mineral content during pregnancy, and increased bone turnover. Purpose To present a c